SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

LIEPMANN HOLGER A

(Last)

(First)

(Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK

60064-6400

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/15/2004

3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Senior Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value	61,412	D
Common shares without par value	12,633⁽¹⁾	I	profit sharing trust
Common shares without par value	295⁽²⁾	I	by wife for daughter
Common shares without par value	296⁽²⁾	I	by wife for daughter

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)⁽³⁾	02/13/2001	02/12/2008	Common shares	2,702	$37	D
Option (right to buy)⁽³⁾	05/17/1999	04/28/2004	Common shares	628	$47.58	D
Option (right to buy)⁽³⁾	05/17/1999	12/31/2004	Common shares	1,880	$47.58	D
Option (right to buy)⁽³⁾	02/12/2000	02/11/2009	Common shares	3,667	$45.22	D
Option (right to buy)⁽³⁾	02/12/2001	02/11/2009	Common shares	3,667	$45.22	D
Option (right to buy)⁽³⁾	02/12/2002	02/11/2009	Common shares	3,666	$45.22	D
Option (right to buy)⁽³⁾	02/11/2002	02/10/2010	Common shares	4,833	$34.7	D
Option (right to buy)⁽³⁾	02/11/2003	02/10/2010	Common shares	4,833	$34.7	D
Option (right to buy)⁽³⁾	02/09/2002	02/08/2011	Common shares	4,834	$48.36	D
Option (right to buy)⁽³⁾	02/09/2003	02/08/2011	Common shares	4,833	$48.36	D
Option (right to buy)⁽³⁾	02/09/2004	02/08/2011	Common shares	4,823	$48.36	D
Option (right to buy)⁽³⁾	07/09/2002	07/08/2011	Common shares	5,000	$47.47	D
Option (right to buy)⁽³⁾	07/09/2003	07/08/2011	Common shares	5,000	$47.47	D
Option (right to buy)⁽³⁾	07/09/2004	07/08/2011	Common shares	5,000	$47.47	D
Option (right to buy)⁽³⁾	06/22/2002	02/13/2007	Common shares	5,150	$55.6	D
Option (right to buy)⁽³⁾	06/22/2002	04/27/2005	Common shares	3,073	$55.6	D
Option (right to buy)⁽³⁾	06/22/2002	02/10/2010	Common shares	3,727	$55.6	D
Option (right to buy)⁽³⁾	06/22/2002	02/12/2008	Common shares	6,289	$55.6	D
Option (right to buy)⁽³⁾	02/15/2003	02/14/2012	Common shares	16,667	$57.06	D
Option (right to buy)⁽³⁾	02/15/2004	02/14/2012	Common shares	16,666	$57.06	D
Option (right to buy)⁽³⁾	02/15/2005	02/14/2012	Common shares	16,667	$57.06	D
Option (right to buy)⁽³⁾	02/14/2004	02/13/2013	Common shares	20,000	$35.36	D
Option (right to buy)⁽³⁾	02/14/2005	02/13/2013	Common shares	20,000	$35.36	D
Option (right to buy)⁽³⁾	02/14/2006	02/13/2013	Common shares	20,000	$35.36	D
Option (right to buy)⁽³⁾	11/30/2003	02/08/2006	Common shares	1,939	$43.55	D
Option (right to buy)⁽³⁾	11/30/2003	02/13/2007	Common shares	2,650	$43.55	D
Option (right to buy)⁽³⁾	02/20/2005	02/19/2014	Common shares	10,000	$43.66	D
Option (right to buy)⁽³⁾	02/20/2006	02/19/2014	Common shares	10,000	$43.66	D
Option (right to buy)⁽³⁾	02/20/2007	02/19/2014	Common shares	10,000	$43.66	D

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of March 17, 2004.

2. Reporting person disclaims beneficial ownership of shares held by his daughters.

3. Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

	John A. Berry, Attorney-in-Fact for Holger A. Liepmann	03/22/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.